Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Treasury Shares: 2013-2025

Historic Treasury Shares for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to $5.1 million.

  • Fortress Biotech's Treasury Shares rose 185.20% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 185.20%. This contributed to the annual value of $4.4 million for FY2024, which is 113.60% up from last year.
  • Latest data reveals that Fortress Biotech reported Treasury Shares of $5.1 million as of Q3 2025, which was down 11.00% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Treasury Shares ranged from a high of $23.0 million in Q1 2023 and a low of $1.4 million during Q4 2022.
  • Moreover, its 3-year median value for Treasury Shares was $4.4 million (2024), whereas its average is $6.9 million.
  • Per our database at Business Quant, Fortress Biotech's Treasury Shares surged by 368,650.26% in 2021 and then crashed by 92.83% in 2023.
  • Quarterly analysis of 5 years shows Fortress Biotech's Treasury Shares stood at $18.1 million in 2021, then slumped by 92.41% to $1.4 million in 2022, then soared by 50.86% to $2.1 million in 2023, then spiked by 113.60% to $4.4 million in 2024, then surged by 185.20% to $5.1 million in 2025.
  • Its Treasury Shares was $5.1 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.5 million in Q1 2025.